Phase I/II Trial of Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)

Next Previous
Trial Profile

Phase I/II Trial of Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 Dec 2017

At a glance

  • Drugs Palbociclib (Primary) ; Bicalutamide
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 09 Dec 2017 Results (n=15, data cut off: 5/11/17) presented at the 40th Annual San Antonio Breast Cancer Symposium
    • 11 Oct 2016 Preliminary Phase I safety results (n=7) presented at the 41st European Society for Medical Oncology Congress
    • 07 Jun 2016 Trial design presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top